» Articles » PMID: 38561803

HIV Risk and Interest in Preexposure Prophylaxis in Justice-Involved Persons

Abstract

Preexposure prophylaxis (PrEP) is underused in persons who use drugs and justice-involved persons. In an ongoing randomized controlled trial in 4 US locations comparing patient navigation versus mobile health unit on time to initiation of HIV medication or PrEP for justice-involved persons who use stimulants or opioids and who are at risk for or living with HIV, we assessed HIV risk factors, perceived HIV risk, and interest in PrEP. Participants without HIV (n = 195) were 77% men, 65% White, 23% Black, and 26% Hispanic; 73% reported a recent history of condomless sex, mainly with partners of unknown HIV status. Of 34% (67/195) reporting injection drug use, 43% reported sharing equipment. Despite risk factors, many persons reported their risk for acquiring HIV as low (47%) or no (43%) risk, although 51/93 (55%) with PrEP indications reported interest in PrEP. Justice-involved persons who use drugs underestimated their HIV risk and might benefit from increased PrEP education efforts.

Citing Articles

Pre-exposure prophylaxis implementation during incarceration: Perspectives of formerly incarcerated men and women.

Banyas E, Castleman M, Rahim H, Okumu E, White B PLoS One. 2024; 19(12):e0311289.

PMID: 39666731 PMC: 11637367. DOI: 10.1371/journal.pone.0311289.


Carceral Health is Public Health.

Hagan L, Mosites E, Hughes-Baker L, Butler J Emerg Infect Dis. 2024; 30(13):S1-S4.

PMID: 38561635 PMC: 10986829. DOI: 10.3201/eid3013.240258.

References
1.
Genberg B, Astemborski J, Vlahov D, Kirk G, Mehta S . Incarceration and injection drug use in Baltimore, Maryland. Addiction. 2015; 110(7):1152-9. PMC: 4478154. DOI: 10.1111/add.12938. View

2.
Rutledge R, Madden L, Ogbuagu O, Meyer J . HIV Risk perception and eligibility for pre-exposure prophylaxis in women involved in the criminal justice system. AIDS Care. 2018; 30(10):1282-1289. PMC: 6085161. DOI: 10.1080/09540121.2018.1447079. View

3.
Nunn A, Zaller N, Cornwall A, Mayer K, Moore E, Dickman S . Low perceived risk and high HIV prevalence among a predominantly African American population participating in Philadelphia's Rapid HIV testing program. AIDS Patient Care STDS. 2011; 25(4):229-35. PMC: 3068868. DOI: 10.1089/apc.2010.0313. View

4.
Springer S, Nijhawan A, Knight K, Kuo I, Di Paola A, Schlossberg E . Study protocol of a randomized controlled trial comparing two linkage models for HIV prevention and treatment in justice-involved persons. BMC Infect Dis. 2022; 22(1):380. PMC: 9013109. DOI: 10.1186/s12879-022-07354-x. View

5.
Stone J, Fraser H, Lim A, Walker J, Ward Z, MacGregor L . Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect Dis. 2018; 18(12):1397-1409. PMC: 6280039. DOI: 10.1016/S1473-3099(18)30469-9. View